Varian Medical Systems
) upgraded Clinac medical linear accelerator was used for the first
time in India at Yashoda Cancer Institute - a cancer center based
in Hyderabad - for advanced lung, liver and brain radiotherapy
With High Intensity Mode dose delivery capability, this accelerator
from VAR allows doctors to shorten treatment times and deliver
stereotactic body radiotherapy and stereotactic radiosurgery for
tumors that are difficult to treat.
Stereotactic body radiotherapy and stereotactic radiosurgery
require fewer treatment sessions for the delivery of the total
dose, with a greater portion of the dose delivered each session.
Thus, the conventional treatment times of five to six weeks can be
reduced to just a few days. This benefits the patients by reducing
the number of times they need to visit the hospital, in turn
helping them get back to their normal routine quickly.
By offering an alternative to surgery, VAR's High Intensity Mode
accelerator also plays an important role in the treatment of
elderly lung cancer patients who are considered inoperable.
In addition to stereotactic treatments, the cancer center also uses
VAR's advanced accelerator in combination with the latter's
image-guided RapidArc radiotherapy to treat tumors. With the
RapidArc technology, the machine moves in a circular motion around
the patient. During the rotation, the beam is constantly shaped and
reshaped to match the shape and size of the tumor, hence delivering
quick and accurate treatment.
The adoption of VAR's upgraded accelerator at Yashoda Cancer
Institute is in line with the objective of a recent Oncology Summit
organized by the company in Mumbai, India. The summit addressed a
wide range of topics in the sphere of radiotherapy and radiosurgery
Amongst other things, the convention focused on major advances in
radiation oncology technology, emerging technologies to treat
different types of cancer, expanding cancer care access in India
and other countries, regulatory issues in radiotherapy practice and
new medical options for cancer patients.
VAR continues to deliver revolutionary capabilities in radiotherapy
and radiosurgery to advance precise, accurate and efficient
treatment for cancer patients around the world.
Last month, VAR inked a $20 million deal with Prime Healthcare
Services - one of the largest privately owned hospital networks in
the U.S. - to be its exclusive technology supplier for image-guided
radiotherapy and radiosurgery. The seven-year agreement with VAR
aims at enhancing and extending radiotherapy and radiosurgery
cancer treatment capabilities at Prime Healthcare.
In April this year, VAR also cut a similar deal with UnityPoint
Health to exclusively supply software and devices for image-guided
radiotherapy and radiosurgery. Going forward, VAR has more of such
multi-year deals in the pipeline that will offer integrated,
accountable and coordinated care.
Currently, VAR carries a Zacks Rank #3 (Hold). Some better-ranked
medical instruments stocks include
Alphatec Holdings, Inc.
). While Accuray and Masimo sport a Zacks Rank #1 (Strong Buy),
Alphatec Holdings carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
VARIAN MEDICAL (VAR): Free Stock Analysis
ACCURAY INC (ARAY): Free Stock Analysis Report
MASIMO CORP (MASI): Free Stock Analysis Report
ALPHATEC HLDGS (ATEC): Free Stock Analysis
To read this article on Zacks.com click here.